Drug Hunter™ is an essential resource for the community of R&D innovators turning molecules into medicines. Drug Hunter distills the science behind emerging drugs and technologies into an easy-to-read and simple-to-search reference. The company was founded in 2018 out of a scientist’s frustration with existing ways to learn about new drugs and the science of pharma. Now, thousands of R&D leaders from every major pharma and biotech company in the world choose to invest their time in Drug Hunter over crawling through the literature alone.
Our products and subscription services including drughunter.com, the Drug Hunter Newsletter, Drug Hunter Events, and Drug Hunter Premium subscription distill the science behind drug discovery, helping innovators keep up with best practices, find ideas, and identify partners with a fraction of the time and cost. Drug Hunter products and services are used by researchers at every major pharma and biotech in the world, leading universities like Harvard, and top VC and equity research firms.
If you’re here reading about drug discovery for fun, you’re probably a drug hunter. If so, we’re here to help!
Our mission is to empower the innovators seeking tomorrow’s medicines. We’ve started to accomplish this by providing products and services that help drug hunters at every stage of drug discovery, from finding new ideas to discovering partners for their clinical candidates. Drughunter.com is the go-to resource for drug discovery innovators to learn and grow their careers in modern drug discovery. Our Drug Hunter newsletter inspires leaders in nearly every pharmaceutical R&D company worldwide with examples of molecules that matter. Experienced professionals can get the science behind emerging drugs served directly with a Premium subscription. Drug Hunter Events are the best place to connect with our community of drug discovery innovators. We’re constantly finding new ways to support drug hunters, and this is just the beginning.
Subscribers to Drug Hunter typically have >12 years of industry experience, nearly half have been drug hunting for two decades or longer, and a significant number serve as senior executives at major public pharma and biotech companies. Drug Hunter subscribers work in every major public pharma and biotech company in the world, act as venture capitalists and investors, and are generally interested in bringing useful medicines to society.
We believe in:
Facts: we’re built on science and data, not opinion or manipulation
Community: drugs are discovered by a community effort, not individuals
Clarity: effective communication is key in a team sport like drug discovery
Curation: your time is valuable, so our information is visual, contextualized, easy to access and comprehend
Context: “why” matters – we don’t share information without tying it to why its important
Why We Started
We love the science and impact of drug discovery. We were tired of seeing only negative press about our amazing industry, so we decided to build something online that’s useful to people like us.
Drug Hunter exists to help drug hunters do what they do best, and celebrate the milestones and knowledge-generating setbacks along the way. Drug Hunter was founded by a drug discovery scientist, and will always be run with a science focus.
If there are more ways we can help you, or if you want to help us in our mission, please get in touch!
“Drug Hunter has a great overview of what is happening in our field, saves time on scouring through news feeds, literature and irrelevant stuff that comes up. It is a tool specifically for people like me to weed out the noise. Big time saver.”
Drug Discovery Scientist, Denali Therapeutics / Publicly Listed Biotech
“I look forward to reading the summaries that come out every month. It helps me keep up to date on what’s going on in the industry.”
Senior Director, Head of Medicinal Chemistry, Eikon Therapeutics / VC-Backed Biotech
“When I need to find information, I know that I can find it on Drug Hunter. This is what was always missing in our field. I’ve been designing drugs for years and the most frustrating part is learning on your own. You may need to go through hundreds of articles to find the information you need. Drug Hunter cuts down on a lot of this!”
Associate Director, Drug Discovery, Essa Pharma / Publicly Listed Biotech
“Drug Hunter helps keep me up to date with the scientific literature and saves me so much valuable time. Please continue the excellent work!”
Senior Director of Medicinal Chemistry, Protagonist Therapeutics / Publicly Listed Biotech
“The thing I like most about it is the concise, to-the-point presentation of the relevant information in an easily digestible format, that is readily accessible to all, from experienced drug hunters to scientists who are just starting their careers. The time-savings achieved by using Drug Hunter are another major selling point. Keep up the good work, folks!”
Executive Director, Science and Strategy Advisor, Astellas Pharma
“I like Drug Hunter! I realize that the team puts so much time and effort into this work and it is not easy work. It is a key opinion leader in the industry. I want Drug Hunter to go on forever. It’s really good!”
Founder and CEO, Arum Therapeutics / Privately Held Biotech
“The cheat sheets that are published are great. Having a centralized resource of those is super helpful. When I recently onboarded a new team member, I taught her about Topliss trees using Drug Hunter. I am way more on top of the med. chem literature because of Drug Hunter!”
Senior Scientist, Medicinal Chemistry, Vividion Therapeutics
“I don’t know of anything similar to this. It’s great that I can visit the site and get a pointer to recent important papers in the field. With the article annotations, I also get a perspective I may not get just by reading papers myself.”
Computational Chemist, PostEra
“I know I can find new information, targets, and compounds on Drug Hunter each month, which has been really helpful. It’s a good website to see the latest news in drug discovery!”
Senior Group Leader, Pharmaron
“Drug Hunters highly informed, relevant science, category-leading approach is time saving, cost saving and importantly a consistent source of inspiration for new Product Development programs. More like this please Drug Hunter!”
Director of Business Development, Pharmalex
“I like that Drug Hunter shows condensed information about what is at the forefront of medicinal chemistry at the moment. The molecules are great, I would otherwise have to sift through a lot of articles to find these drugs. I am very satisfied with Drug Hunter.”
Medicinal Chemist, RAPT Therapeutics / Publicly Listed Biotech
As both an academic and (most recently) an industrial medicinal chemist, the Drug Hunter resources have been very helpful so far. I’ve passed along several of the excellent primer/cheat sheets to my own students, and the lists of CROs and investors have been helpful for company building. Of course, the Molecules of the Month, and the deep science and strategy behind their structures shared in…
Academic, Industrial Chemist
JOIN SUBSCRIBERS from
- Johnson & Johnson
- Eli Lilly
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Novo Nordisk
- Merck KGaA
- Celgene (BMS)
- Biogen |Astellas
- Daiichi Sankyo
- Kyowa Kirin
- LEO Pharma
- RA Capital
- ARCH Venture Partners
- MPM Capital
- The Column Group
- 5AM Ventures
- Versant Ventures
- Goldman Sachs
- Piper Sandler
- …and hundreds of others
- Drug Discovery Resources
- Drug Discovery Posters and Cheat Sheets
- Drug Discovery IPOs and Industry Reviews
- Lists of Approved Drugs
- Classics in Drug Discovery
- Drug Discovery Books
- Drug Discovery Conferences
- What is a Drug Hunter?
- Topliss Tree and Topliss Scheme Posters
- PK Reference Table / Cheat Sheet
- Pd-Couplings Table / Cheat Sheet